233 related articles for article (PubMed ID: 12074273)
21. Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.
Terada R; Warren S; Lu JT; Chien KR; Wessels A; Kasahara H
Cardiovasc Res; 2011 Jul; 91(2):289-99. PubMed ID: 21285290
[TBL] [Abstract][Full Text] [Related]
22. Congenital heart defect causing mutation in Nkx2.5 displays in vivo functional deficit.
Zakariyah AF; Rajgara RF; Veinot JP; Skerjanc IS; Burgon PG
J Mol Cell Cardiol; 2017 Apr; 105():89-98. PubMed ID: 28302382
[TBL] [Abstract][Full Text] [Related]
23. Up-regulation of natriuretic peptides in the ventricle of Csx/Nkx2-5 transgenic mice.
Takimoto E; Mizuno T; Terasaki F; Shimoyama M; Honda H; Shiojima I; Hiroi Y; Oka T; Hayashi D; Hirai H; Kudoh S; Toko H; Kawamura K; Nagai R; Yazaki Y; Komuro I
Biochem Biophys Res Commun; 2000 Apr; 270(3):1074-9. PubMed ID: 10772952
[TBL] [Abstract][Full Text] [Related]
24. Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein.
Kasahara H; Usheva A; Ueyama T; Aoki H; Horikoshi N; Izumo S
J Biol Chem; 2001 Feb; 276(7):4570-80. PubMed ID: 11042197
[TBL] [Abstract][Full Text] [Related]
25. R25C mutation in the NKX2.5 gene in Italian patients affected with non-syndromic and syndromic congenital heart disease.
Beffagna G; Cecchetto A; Dal Bianco L; Lorenzon A; Angelini A; Padalino M; Vida V; Bhattacharya S; Stellin G; Rampazzo A; Daliento L
J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):582-6. PubMed ID: 22964646
[TBL] [Abstract][Full Text] [Related]
26. NKX2.5 mutations in patients with non-syndromic congenital heart disease.
Gioli-Pereira L; Pereira AC; Mesquita SM; Xavier-Neto J; Lopes AA; Krieger JE
Int J Cardiol; 2010 Feb; 138(3):261-5. PubMed ID: 19073351
[TBL] [Abstract][Full Text] [Related]
27. Novel point mutation in the NKX2-5 gene in a Moroccan family with atrioventricular conduction disturbance and an atrial septal defect in the oval fossa.
Rifai L; Maazouzi W; Sefiani A
Cardiol Young; 2007 Feb; 17(1):107-9. PubMed ID: 17184575
[TBL] [Abstract][Full Text] [Related]
28. [Gene mutation in secundum atrial septal defect: analysis of a Chinese family with 3 patients].
Tian L; Zhu JF; Yang JG; Zhu QH; Du R; Li J; Li W
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):250-3. PubMed ID: 18361836
[TBL] [Abstract][Full Text] [Related]
29. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect.
Hirayama-Yamada K; Kamisago M; Akimoto K; Aotsuka H; Nakamura Y; Tomita H; Furutani M; Imamura S; Takao A; Nakazawa M; Matsuoka R
Am J Med Genet A; 2005 May; 135(1):47-52. PubMed ID: 15810002
[TBL] [Abstract][Full Text] [Related]
30. Identification of the in vivo casein kinase II phosphorylation site within the homeodomain of the cardiac tisue-specifying homeobox gene product Csx/Nkx2.5.
Kasahara H; Izumo S
Mol Cell Biol; 1999 Jan; 19(1):526-36. PubMed ID: 9858576
[TBL] [Abstract][Full Text] [Related]
31. The Polycomb-group gene Rae28 sustains Nkx2.5/Csx expression and is essential for cardiac morphogenesis.
Shirai M; Osugi T; Koga H; Kaji Y; Takimoto E; Komuro I; Hara J; Miwa T; Yamauchi-Takihara K; Takihara Y
J Clin Invest; 2002 Jul; 110(2):177-84. PubMed ID: 12122109
[TBL] [Abstract][Full Text] [Related]
32. Functional analyses of three Csx/Nkx-2.5 mutations that cause human congenital heart disease.
Zhu W; Shiojima I; Hiroi Y; Zou Y; Akazawa H; Mizukami M; Toko H; Yazaki Y; Nagai R; Komuro I
J Biol Chem; 2000 Nov; 275(45):35291-6. PubMed ID: 10948187
[TBL] [Abstract][Full Text] [Related]
33. Csx/Nkx2-5 is required for homeostasis and survival of cardiac myocytes in the adult heart.
Toko H; Zhu W; Takimoto E; Shiojima I; Hiroi Y; Zou Y; Oka T; Akazawa H; Mizukami M; Sakamoto M; Terasaki F; Kitaura Y; Takano H; Nagai T; Nagai R; Komuro I
J Biol Chem; 2002 Jul; 277(27):24735-43. PubMed ID: 11889119
[TBL] [Abstract][Full Text] [Related]
34. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.
Hiroi Y; Kudoh S; Monzen K; Ikeda Y; Yazaki Y; Nagai R; Komuro I
Nat Genet; 2001 Jul; 28(3):276-80. PubMed ID: 11431700
[TBL] [Abstract][Full Text] [Related]
35. Novel NKX2-5 mutations in diseased heart tissues of patients with cardiac malformations.
Reamon-Buettner SM; Hecker H; Spanel-Borowski K; Craatz S; Kuenzel E; Borlak J
Am J Pathol; 2004 Jun; 164(6):2117-25. PubMed ID: 15161646
[TBL] [Abstract][Full Text] [Related]
36. Biochemical analyses of eight NKX2.5 homeodomain missense mutations causing atrioventricular block and cardiac anomalies.
Kasahara H; Benson DW
Cardiovasc Res; 2004 Oct; 64(1):40-51. PubMed ID: 15364612
[TBL] [Abstract][Full Text] [Related]
37. [Genetic screening of Gata4 and Nkx2.5 mutations in hereditary congenital heart defects: 5 familial cases].
Pulignani S; Foffa I; Cresci M; Vittorini S; Ait-Ali L; Andreassi MG
Recenti Prog Med; 2011 Mar; 102(3):120-5. PubMed ID: 21572484
[TBL] [Abstract][Full Text] [Related]
38. A novel LIM protein Cal promotes cardiac differentiation by association with CSX/NKX2-5.
Akazawa H; Kudoh S; Mochizuki N; Takekoshi N; Takano H; Nagai T; Komuro I
J Cell Biol; 2004 Feb; 164(3):395-405. PubMed ID: 14757752
[TBL] [Abstract][Full Text] [Related]
39. Somatic NKX2-5 mutations as a novel mechanism of disease in complex congenital heart disease.
Reamon-Buettner SM; Borlak J
J Med Genet; 2004 Sep; 41(9):684-90. PubMed ID: 15342699
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and spectrum of Nkx2.6 mutations in patients with congenital heart disease.
Zhao L; Ni SH; Liu XY; Wei D; Yuan F; Xu L; Xin-Li ; Li RG; Qu XK; Xu YJ; Fang WY; Yang YQ; Qiu XB
Eur J Med Genet; 2014 Oct; 57(10):579-86. PubMed ID: 25195019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
